Abstract
It has only been since the late 1940s that chemotherapy emerged as part of the therapeutic armamentarium for treating patients with disseminated breast cancer. Recently, however, the role of chemotherapeutic agents in prolonging life and disease-free interval in patients with breast cancer has come to be questioned.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Baker LM (1982) Breast cancer detection demonstration project: Five-year summary report. CA 32: 194–225
Byrd BF Jr (1981) Breast cancer detection center projects in breast cancer, vol 4. Plenum, New York
Cody HS III et al. (1982) The continuing importance of adequate surgery for operable breast cancer: significant salvage of node positive patients in that adjuvant chemotherapy. CA 32: 242–252
Fisher B et al. (1969) Cancer of the breast. Size of neoplasm and prognosis. Cancer 24: 1071–1080
Seidman H et al. (1982) A different perspective on breast cancer risk factors: some implications of the non-attributable risk. CA 32: 301–313
Silverberg E (1984) Cancer statistics, 1984. CA 34: 7–23
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Hartmann, W.H. (1984). Impact of Early Detection of Breast Cancer on Adjuvant Chemotherapy. In: Senn, HJ. (eds) Adjuvant Chemotherapy of Breast Cancer. Recent Results in Cancer Research, vol 96. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82357-2_4
Download citation
DOI: https://doi.org/10.1007/978-3-642-82357-2_4
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82359-6
Online ISBN: 978-3-642-82357-2
eBook Packages: Springer Book Archive